Mutagenesis, Vol. 15, No. 2, 105-108,
March 2000
© 2000 UK Environmental Mutagen Society/Oxford University Press
Altered splicing of the ATDC message in ataxia telangiectasia group D cells results in the absence of a functional protein
SRI International, 333 Ravenswood Boulevard, Menlo Park, CA 94025, USA
| Abstract |
|---|
|
|
|---|
The ATDC gene was cloned using functional complementation and complements the radiosensitivity of ataxia telangiectasia (AT) group D cells. Although a number of transcripts have been detected, only a 3.0 kb cDNA found in a HeLa cell cDNA library has been cloned. Since AT group D cells express only a 2.4 kb transcript, efforts were made to clone and sequence this transcript. Using a biotinylated oligonucleotide probe, mRNA preparations were enriched in ATDC-related sequences. After this enrichment, 2.4 kb clones were obtained from the resulting library. The 2.4 kb transcript appears to be untranslated, since no protein from this transcript has been detected in AT group D cells, and this transcript is probably non-functional, since a splicing variation has positioned part of intron 1 near the first methionine codon in exon 1, eliminating most of exon 1 and important functional regions from this transcript. This transcript now has a stop codon located 33 bp in front of the first methionine, which would stop translation after the eleventh amino acid. As a result of these changes, the AT group D cell line (AT5BI) expresses no functional ATDC protein.
| Introduction |
|---|
|
|
|---|
The ATDC gene complements radiation sensitivity in AT5BI cells, an ataxia telangiectasia (AT) complementation group D cell line. It has a complex expression pattern and up to nine different transcripts have been detected in various cell lines (Hosoi and Kapp, 1994
Since AT5BI group D cells express only the ATDC 2.4 kb transcript, and this was not cloned in previous work, the aim of the work described here was to clone this 2.4 kb ATDC transcript expressed in AT group D cells and to sequence it to determine if it could produce a functional protein.
| Materials and methods |
|---|
|
|
|---|
Cell lines
HS27 cells are a normal human diploid fibroblast cell strain obtained from the Cell Culture Facility at UCSF. AT5BIVA group D transformed cells (GM5849) were used as a source for mRNA. These cells are also called TAT5 cells. These cells were obtained from the Human Genetic Mutant Cell Repository (Camden, NJ). Cells were grown in MEM supplemented with 15% fetal calf serum, glutamine (Gibco) and pennicillin/streptomycin (Gibco).
ATDC9 cells are AT5BIVA cells complemented with the ATDC gene in an expression vector and which have a near normal radiosensitivity.
Construction of an enriched ATDC cDNA library
An AT5BI cDNA library was constructed using conventional methods (Sambrook et al., 1989
). More than 5x106 primary plaques were screened using a full-length 3.0 kb ATDC cDNA as probe. However, the 2.4 kb ATDC transcript was not present in the library. In order to find this apparently rare transcript, another method of constructing a cDNA library was tried. To construct a cDNA library which contains a high percentage of ATDC cDNA, the protocol used with the Cap-finder cDNA library construction kit from Clontech was modified. The kit protocol is based on the use of a 5'-cap oligonucleotide and long distance PCR. A hybridization step was added after the first strand synthesis in order to concentrate the rare ATDC-related transcripts. Biotinylation of the oligonucleotide was achieved by biotin-14dCTP addition to the 3'-end of the products with terminal deoxynucleotidyl transferase.
Poly(A) RNA was isolated from AT5BI cells using a Fast Track mRNA isolation kit (Invitrogen) and the first DNA strand was synthesisized using MMLV reverse transcriptase with an oligo(dT) primer and a 5'-cap-switch oligonucleotide (Clontech). The first strand DNAs were hybridized with a biotinylated oligonucleotide from an ATDC exon 2 sequence (5'-GCCACTTCTCAGCTTCATCCTCAA-3'). This sequence was selected for concentration of ATDC sequences for several reasons. Previous data showed that very low levels of the ATDC mRNA containing exons 38 should be present, even in SV40-transformed AT group D cells (Hosoi and Kapp, 1994
), and exon 2 and the 5'-region of exon 3 encode a leucine zipper that may be an important functional region for ATDC protein (Leonhardt et al., 1994
).
Hybridization was performed in 6x SSPE, 0.1% SDS and 5x Denhardt's solution at 48°C for 1 h. At the end of the hybridization, streptavidin-coated magnetic beads (Dynabeads M-280 streptavidin; Dynal) were added to the solution. The mixture was incubated at room temperature for 30 min and the beads were collected with a magnet. The collected beads were washed three times with a washing solution consisting of 0.1x SSC, 0.1% SDS and 1 mM EDTA. Hybridized single-strand DNAs were eluted from the beads by incubation in an elution solution (50 mM NaOH, 1 mM EDTA). Eluted DNA was neutralized by the addition of one half volume of 7.5 M ammonium acetate and then ethanol precipitated. The pellet was dissolved in 15 µl of deionized, Milli-Q (Millipore)-treated sterile water and used as a template for a long distance PCR reaction (LD-PCR). After LD-PCR with a 5'-cap oligonucleotide and an oligo(dT) primer for 25 cycles, double-stranded cDNA was blunted with a T4 DNA polymerase reaction and ligated with EcoRI/NotI/SalI adapters (Clontech). The cDNA was then phosphorylated, ligated with
gt11 vector arms, packaged with a Gigapack Gold kit (Stratagene) and transformed into host Escherichia coli strain Y1090r. The average titer of the primary cDNA libraries was 0.51.0x106 p.f.u. and the percentage of recombinants was ~90%.
Library screening
Full-length (3018 bp) ATDC cDNA was used as a probe for detecting the ATDC message from AT5BI cells. Hybridization was performed in a solution containing 50% formamide (Sigma), 6x SSPE, 0.5% SDS, 5x Denhardt's solution and 0.1 mg/ml sonicated salmon sperm DNA. Membranes were washed with 0.1x SSC, 0.1% SDS at 55°C for 25 min and exposed to X-ray film. Positive plaques were transferred to SM buffer and then secondary screening was performed.
Isolated clones were expanded in NZY medium (Gibco) and phage DNA was extracted as described elsewhere (Sambrook et al., 1989
).
Sequence analysis
Insert cDNA was excised with an EcoRI digest and subcloned into the pBluescript II KS() vector (Stratagene). Nucleotide sequence analysis was performed with Sequenase version 2 according to the manufacturer's instructions (Amersham) using purified plasmid DNA prepared with Qiagen P-20 columns (Qiagen). T7 and T3 primers were purchased from Stratagene and sequence-specific primers were purchased from the Midland Certified Reagent Company. For cosmid sequence analysis, a SequiTherm EXCEL II Long-Read DNA Sequencing Kit-LC (Epicenter Technologies) and a DNA sequencer 4000L (LI-COR) were used.
Northern analysis
Northern hybridization was performed as described elswhere (Sambrook et al., 1989
). Briefly, 2 µg of poly(A)+ RNA was subjected to agarose gel electrophoresis and then blotted onto a Hybond N+ membrane (Amersham). The filter was then hybridized with 32P-labeled full-length ATDC cDNA at 42°C in a solution containing 50% formamide (Sigma), 5x SSPE, 0.5% SDS, 5x Denhardt's and 0.1 mg/ml sonicated salmon sperm DNA. Membranes were washed with 0.1x SSC, 0.1% SDS at 55°C for 20 min and exposed to X-ray film.
Western blots
Western analysis was performed as described previously (Laderoute et al., 1996
). Cell cultures were washed once with ice-cold phosphate-buffered saline (PBS) and lysed in an ice-cold buffer containing 50 mM TrisHCl (pH 7.4), 250 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM sodium orthovanadate, 20 µg/ml aprotinin, 1 mM PMSF and 5 µg/ml leupeptin. Lysates were frozen in dry ice and stored at 80°C. Frozen lysates were thawed on ice and centrifuged at 10 000 g for 5 min at 4°C. Protein concentrations of the supernatants were measured using a BCA assay (Pierce, Rockford, IL). Protein samples for gel electrophoresis were diluted with equal volumes of a 2x SDS buffer containing 125 mM TrisHCl (pH 6.8), 4.6% SDS, 10% mercaptoethanol and 20% glycerol and boiled for 5 min. Proteins were resolved in discontinuous 8% SDSpolyacrylamide gels and electroblotted in buffer containing 24 mM TrisHCl (pH 8.3), 192 mM glycine and 15% methanol onto Immobilon P membranes (Millipore, Marlborough, MA) using the TR 70 Semiphor Semi-Dry Transfer Unit (Hoefer, San Francisco, CA). Membranes were incubated in 1% non-fat dried milk at 4°C overnight and then at room temperature for 4 h with rabbit anti-human ATDC antiserum or pre-immune serum diluted 1:1000 in PBS containing 5% horse serum. Antibody binding was detected using a biotin-labeled anti-rabbit IgG antibody (Vector, Burlingame, CA), streptavidinalkaline phosphatase (Vector) and the substrates NBT and BCIP (Life Technologies, Gaithersburg, MD).
| Results |
|---|
|
|
|---|
An AT5BI cDNA library was constructed using conventional methods (Sambrook et al., 1989
Since standard methods of library construction failed to include the 2.4 kb ATDC transcript which was detected in northern blots, the protocol used to construct the AT5BI cell cDNA library was modified. The purpose of the modification was to enrich the library with ATDC transcripts.
A biotinylated oligonucleotide probe was used to concentrate the ATDC-related transcripts in the original cDNA library. Briefly, the first strand cDNA with a 5'-cap-switch oligonucleotide (Clontech) was hybridized to a biotinylated oligonucleotide containing the ATDC exon 2 sequence 5'-GCCACTTCTCAGCTTCATCCTCAA-3'. The hybridized cDNAs were collected using streptavidin-coated magnetic beads, followed by LD-PCR with the 5'-cap oligonucleotide and oligo(dT) primers. The amplified cDNA was blunted, phosphorylated and ligated into a
gt11 vector. This library was then grown and screened for ATDC sequences.
This approach efficiently enriched the library in ATDC-positive clones, which were normally present at very low concentrations. From the enriched library, nine ATDC-positive clones were obtained out of a total of 2.5x104 plaques, or one positive clone per 2.7x103 plaques. Out of these nine clones, five contained a 2.4 kb insert, one clone contained a 2.0 kb insert and the remaining four clones contained inserts which were ~1.0 kb in length but did not contain the 3'-region of ATDC.
The sequence of the new 2.4 kb clone was compared with the intron 1 region near exon 2 in the K1 cosmid, which contains the 5'-half of the ATDC genomic sequence (Kapp et al., 1992
). This comparison showed that a part of intron 1 just upstream of exon 2 had been spliced into the 5'-region of exon 1 just 5' to the methionine codon (Figure 1
). This splicing variation results in the removal of most of exon 1 and its replacement with a part of intron 1 from the genomic sequence upstream of exon 2 in AT5BIVA AT group D cells.
|
Northern blot analysis using the ATDC exon 1 sequence as a probe detected no 2.4 kb bands in diploid AT5BI group D cells (data not shown). This indicated that the 2.4 kb message in AT5BI group D cells does not contain exon 1 of the 3018 bp ATDC transcript. Additional northern blot analysis was performed using a full-length ATDC cDNA as a probe (Figure 2
|
Previous reports showed that potentially important functional regions of the ATDC gene are located between exons 1 and 3. These exons contain a leucine zipper motif, a zinc finger-like motif (Leonhardt et al., 1994
Western blot analysis showed that two cell lines with normal radioresistance, transformed GM637 cells and diploid HS27 cells, exhibited the presence of full-length ATDC protein (Figure 3
). However, no ATDC protein was detectable in diploid AT5BI cells or in the transformed TAT5 group D cells. These results suggest that the 2.4 kb ATDC transcript in AT group D cells is not translated due to the long 5'-untranslated region with its multiple stop codons which has been introduced into the transcript by the splicing variation. If a peptide is translated, it would have to begin from the mid-point of exon 3 where the next methionine codon is located and, due to the loss of potentially important functional regions, it is not likely to be functional and may not be stable.
|
The 2.4 kb transcript from normal diploid HS27 cells which express a 2.4 and a 1.6 kb transcript (Hosoi and Kapp, 1994
| Discussion |
|---|
|
|
|---|
The ATDC gene was cloned using functional complementation to identify DNA sequences which could complement the radiosensitivity of AT group D cells in culture. Genomic DNA clones of ATDC provided such complementation and originated from 11Q23, although the original clones were truncated (Kapp and Painter, 1989
This suggests that the first 5'-half of the ATDC gene contains most of the activity of the protein. This portion of the gene contains the putative leucine zipper and zinc finger motifs identifying it as a member of an oncogene family (Kakizuka et al., 1991
; Kastner et al., 1992
; Leonhardt et al., 1994
).
After cloning the ATDC genomic DNA fragment, it was used as a probe to locate the 3.0 kb cDNA in a HeLa cell cDNA library (Kapp et al., 1992
), but no other ATDC transcripts were found. This HeLa cell cDNA provided the sequence of the ATDC gene. Although this 3.0 kb ATDC cDNA does complement the radiosensitivity of the AT group D cells as measured by survival, it failed to complement radioresistant DNA synthesis (RDS), a classic hallmark of AT cells (Kapp et al., 1992
). In addition, using SSCP, no mutations were detected in the 3.0 kb ATDC transcript. However, this method is only capable of detecting ~85% of the mutations present (Leonhardt et al., 1994
). Such a separtion of survival and RDS (Green et al., 1987
; Kapp et al., 1992
) in response to X-irradiation adds to the complexity and difficulty of understanding AT.
Further studies of the expression pattern of ATDC showed that as many as nine different transcripts of this gene could be detected in other cell lines, but that only the 2.4 kb transcript was expressed in the AT5BIVA group D cell line. Since this 2.4 kb transcript was the only one expressed in these group D cells, and has not been found in cDNA libraries, its sequence would likely be of value in understanding the behavior of the ATDC gene in AT group D cells. The work described here was intended to clone and sequence this particular transcript. The findings reported here show that the ATDC protein is non-functional or absent in this AT cell line.
Since nine transcripts of ATDC have been detected in various cell lines and not all normal cells express the 3.0 kb ATDC transcript, it appears likely that other ATDC transcripts can be sufficient for proper cellular functioning. In normal LM217 cells the 1.6 kb ATDC transcript is seen as well as a possibly non-functional 2.4 kp transcript (Hosoi and Kapp, 1994
), suggesting that the 2.4 kb ATDC transcript may not be necessary for a normal radiation response. In these cells the 1.6 kb ATDC transcript may code for a functional ATDC protein.
The ATM gene has been found to be mutated in all AT complementation groups, although mutations in both alleles have not always been found (Savitsky et al., 1995
; Wright et al., 1996
; Stankovic et al., 1998
). To date, only one mutated allele of ATM has been detected in the group D cells used here (Savitsky et al., 1995
; Wright et al., 1996
), leaving the relationship between ATM and AT complementation group D unclear. The ATM gene has also been found to have single allele mutations in several normal cell lines used as controls (Wright et al., 1996
), showing that a single allele mutation in ATM is not sufficient to produce radiosensitivity. In AT5BIVA group D cells, ATM has a single allele mutation leading to a truncation of the protein (Savitsky et al., 1995
; Wright et al., 1996
). Accordingly, these AT5BIVA cells should have a normal phenotype with respect to radiation sensitivity and RDS. If these results are correct, the fact that they are AT-like and possibly have one normal ATM allele suggests that other factors could be involved in producing the AT state in these cells. A functional ATDC protein is not expressed in these cells, but the ATDC protein only complements survival and not RDS, which argues that it also could not be the only gene responsible for the AT state in these cells. However, if the ATM gene is mutated in only one allele in these cells, then the role of ATDC could be of importance in understanding the AT status of AT5BIVA cells.
Alternatively, although a mutation of only one allele of ATM has been found in the AT group D cells used here, the possibility remains that these AT group D cells contain another mutation in the genomic sequence of the other ATM allele or in a non-translated region such as its promoter. These could be difficult to locate due to the large size of the ATM gene (Savitsky et al., 1995
).
Assuming that the ATM gene is defective in both AT5BIVA alleles, one model to explain the role of the ATDC gene and protein in AT group D would require that the ATDC gene is necessary for radiation resistance only when the ATM protein has an AT group D type mutation. Since the relationship between ATM mutations and the AT complementation groups is still unclear, an analysis of the ATDC transcript and function could be helpful in identifying the AT group D type mutation in the ATM gene. Although there is a preponderance of null mutations in ATM (Gilad et al., 1996
), some AT patients have full-length ATM proteins with a small internal deletion or amino acid substitution (Stankovic et al., 1998
). These reports suggest that there might be other cellular proteins whose interaction with ATM might be necessary for normal cellular function. Since the ATDC gene complements radiation sensitivity in AT group D cells, it can be considered a candidate for this role.
An understanding of the role of the ATDC gene in AT group D cells, as well as of ATM gene expression in these cells and possibly of the involvement of other genes, yet to be identified, may be required to fully understand and explain AT.
| Note added in proof |
|---|
|
|
|---|
While this paper was in press, Combining Serial Analysis of Gene Expression and Array Technologies to Identify Genes Differentially Expressed in Breast Cancer, by Nacht et al. (Cancer Res., 59, 54645470, 1999) was published. This paper looked at differential gene expression by comparing gene expression in breast tumor cells with expression in normal mammary epithelial cells. Differential expression was observed in a group of genes, and among these the ATDC gene was shown to be expressed at greatly reduced levels in breast tumor cells when compared to expression in normal mammary epithelial cells. This observation is of interest due to the suggested association of breast cancer with AT heterozygotes.
| Acknowledgments |
|---|
This work was partially supported by a grant to Robert Sutherland (NIH PO1 CA67166), a grant to L.K. from the AT Children's project and a grant to H.T. from the Japanese Ministry of Science, Education and Culture.
| Notes |
|---|
1 Present address: Department of Radiation Biology RIRBM, Hiroshima University, Hiroshima 734-8553, Japan
2 To whom correspondence should be addressed at present address: Department of Ophthamology, Box 0730, University of California Medical School, San Francisco, CA 94143, USA. Tel: +1 415 476 5633; Fax: +1 415 459 4791; Email: kapp{at}cgl.ucsf.edu ![]()
| References |
|---|
|
|
|---|
-
Brzoska,P.M., Chen,H., Zhu,Y., Levin,N.K., Disatnik,M.-H., Mochly-Rosi,D., Murnane,J.P. and Christman,M.F. (1995) The product of the ataxia telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor. Proc. Natl Acad. Sci. USA, 92, 78247828.
Gilad,S., Khosravi,R., Shkedy,D., Uziel,T., Ziv,Y., Savitsky,K., Rotman,G., Smith,S., Chessa,L., Jorgenson,T.J. et al. (1996) Predominance of null mutations in ataxia telangiectasia. Hum. Mol. Genet., 5, 433439.
Green,M.H., Lowe,J.E., Arlett,C.F., Harcourt,S.A., Burke,J., James,M.R., Lehmann,A.R. and Povey,S.M. (1987) A gamma-ray-resistant derivative of an ataxia telangiectasia cell line obtained following DNA-mediated gene transfer. J. Cell Sci., suppl. 6, 127137.
Hosoi,Y. and Kapp,L.N. (1994) Expression of a candidate ataxia telangiectasia group D gene in cultured fibroblast cell lines and human tissues. Int. J. Radiat. Biol., 66, S71S76.[Web of Science][Medline]
Kakizuka,A., Miller,W.H.Jr, Umesono,K., Warrell,R.P.Jr, Frankel,S.R., Murty,V.V., Dmitrovsky,E. and Evans,R.M. (1991) Chromosomal translocation (15;17) in human acute promyelocytic leukemia fuses RAR-alpha with a novel putative transcription factor PML. Cell, 66, 663674.[Web of Science][Medline]
Kapp,L.N. and Painter,R.B. (1989) Stable radioresistance in ataxia telangiectasia cells containing DNA from normal cells. Int. J. Radiat. Biol., 56, 667675.[Web of Science][Medline]
Kapp,L.N., Painter,R.B., Yu,L.C., van Loon,N., Richard,C.W., James,M.R., Cox,D.R. and Murnane,J.P. (1992) Cloning of a candidate gene for ataxia telangiectasia group D. Am. J. Hum. Genet., 51, 4554.[Web of Science][Medline]
Kastner,P., Perez,A., Lutz,Y., Rochette-Egly,C., Gaub,M.-P., Durand,B., Lanotte,M., Berger,R. and Chambon,P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J., 11, 629642.[Web of Science][Medline]
Laderoute,K.R., Knapp,A.M., Green,C., Sutherland,R.M. and Kapp,L.N. (1996) Expression of the ATDC gene in A431 human squamous carcinoma cells. Int. J. Cancer, 66, 772778.[Web of Science][Medline]
Leonhardt,E.A., Kapp,L.N., Young,B.R. and Murnane,J.P. (1994) Nucleotide sequence analysis of a candidate gene for ataxia telangiectasia group D (ATDC). Genomics, 19, 130136.[Web of Science][Medline]
Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Savitsky,K. et al. (1995) A single ataxia telangiectasia gene with a product similar to a PI-3 kinase. Science, 268, 17491753.
Stankovic,T., Kidd,A.M., Sutcliffe,A., McGuire,G.M., Robinson,P., Bedenham,T., Bradwell,A.R., Easton,D.F., Lennox,G.G., Haites,N., Byrd,P.J. and Taylor,A.M.R. (1998) ATM mutations in ataxia telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma and breast cancer. Am. J. Hum. Genet., 62, 334345.[Web of Science][Medline]
Wright,J., Teraoka,S., Onengut,S., Tolun,A. Gatti,R.A., Ochs,H.D. and Concannon,P. (1996) A high frequency of distinct ATM gene mutations in ataxia telangiectasia. Am. J. Hum. Genet., 59, 839846.[Web of Science][Medline]
Received on June 1, 1999; accepted on November 5, 1999.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


